Long-acting injectables are transforming schizophrenia treatment by ensuring medication adherence and reducing relapse rates.
When one spouse has a mental illness, the mental health of the other spouse is negatively impacted. Discover some notable ...
Research from Aristotle University of Thessaloniki, Greece reveals that over 26% of stable patients with schizophrenia ...
Even under the best of circumstances, remembering to take a daily pill can be a challenge. For someone living with ...
If the FDA follows an advisory committee’s vote, it can potentially be a transformative step in the delivery of mental health ...
“If cannabis use ‘causes’ schizophrenia, it is absolutely impossible that the rate of schizophrenia would not be going up ...
Ketamine can trigger symptoms similar to those of schizophrenia ... to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other mental health ...
Resilience factors were associated with less severe positive and negative schizophrenia symptoms, suggesting resilience may play a protective role.
The incidence of cannabis use disorder associated with schizophrenia almost tripled among Canadian teenagers and adults after ...
Holder of an innovative diagnostic support technology, recognized by the Food and Drug Administration (FDA) as a major ...
The most recent data shows 96% of people at the state hospital are committed for criminal matters, and 40% of them are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results